ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Foresee announces potential new COVID-19 drug
July 07, 2021Foresee Pharmaceuticals' drug FP-025 to treat acute respiratory distress syndrome in COVID-19 patients has been given a nod from an independent data monitoring committee (IDMC) in the US, reported the Taipei Times. -
Foresee Pharmaceuticals Announces Dosing of First Patient in Phase 2/3 Clinical Trial of FP-025 for Treatment of COVID-19 Associated ARDS
March 29, 2021Foresee Pharmaceuticals Co., Ltd., today announced the initiation of patient dosing in the Phase 2/3 clinical trial of FP-025, its highly selective oral MMP-12 inhibitor, in adult patients with severe to critical COVID-19 with ...
Pharma Sources Insight January 2025
